Higher diversity of anti-diabetic therapy is associated with lower risk of major adverse kidney events in diabetes

doi:10.4239/wjd.123922

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 11

This Article

(2)

(3)

(0)

(164)

Peer-Review Report of This Article

Supplementary Materials of This Article

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Diabetes. Nov 15, 2026; 17(11): 123922
Published online Nov 15, 2026. doi: 10.4239/wjd.123922

Full Size Figure Download Figure

Figure 1 Study flowchart. Study flowcharts for the UK Biobank cohort (left) and the Chongqing diabetes registry (right). HbA1c: Glycated hemoglobin A1c; PSM: Propensity score matching; MAKE: Major adverse kidney event; ESRD: Endstage renal disease.

Citation: Zhang SP, Huang TT, Zeng QL, Luo WJ, Xiong YJ, Peng C, Lian F, Cheng QF, Wang ZH, Huang W, Xu Y, Li QF, Yang SM, Chen XJ, Hu JB, Li XY. Higher diversity of anti-diabetic therapy is associated with lower risk of major adverse kidney events in diabetes. World J Diabetes 2026; 17(11): 123922
URL: https://www.wjgnet.com/1948-9358/full/v17/i11/123922.htm
DOI: https://dx.doi.org/10.4239/wjd.123922

Zhang SP, Huang TT, Zeng QL, Luo WJ, Xiong YJ, Peng C, Lian F, Cheng QF, Wang ZH, Huang W, Xu Y, Li QF, Yang SM, Chen XJ, Hu JB, Li XY. Higher diversity of anti-diabetic therapy is associated with lower risk of major adverse kidney events in diabetes. World J Diabetes 2026; 17(11): 123922 [DOI: 10.4239/wjd.123922]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.